Prevalence and Outcomes Associated with Idarucizumab Administration in Trauma Patients on Preinjury Dabigatran Therapy: Analyzing Clinical Utilization in 942 Patients from 74 Hospitals
Rebecca L. Moore, Ransom J. Wyse, View ORCID ProfileJustin Jacobs, View ORCID ProfileSamir M. Fakhry, View ORCID ProfileNina Y. Wilson, View ORCID ProfileJeneva M. Garland
doi: https://doi.org/10.1101/2024.01.12.24301126
Rebecca L. Moore
1HCA Healthcare/University of Tennessee College of Pharmacy PGY2 Residency Program, Clinical Services Group, HCA Healthcare, Nashville, TN 37203
PharmDRansom J. Wyse
2Center for Trauma and Acute Care Surgery Research, Clinical Services Group, HCA Healthcare, Nashville, TN 37203
MPHJustin Jacobs
3Center for Trauma and Acute Care Surgery Research, Clinical Services Group, HCA Healthcare, Nashville, TN 37203
MSSamir M. Fakhry
4Center for Trauma and Acute Care Surgery Research, Clinical Services Group, HCA Healthcare, Nashville, TN 37203
MDNina Y. Wilson
5Center for Trauma and Acute Care Surgery Research, Clinical Services Group, HCA Healthcare, Nashville, TN 37203
MSNJeneva M. Garland
6Center for Trauma and Acute Care Surgery Research, Clinical Services Group, HCA Healthcare, Nashville, TN 37203
PharmDData Availability
The authors had full access to all data in the study and take responsibility for the integrity of the data and accuracy of the data analysis.
Posted January 13, 2024.
Prevalence and Outcomes Associated with Idarucizumab Administration in Trauma Patients on Preinjury Dabigatran Therapy: Analyzing Clinical Utilization in 942 Patients from 74 Hospitals
Rebecca L. Moore, Ransom J. Wyse, Justin Jacobs, Samir M. Fakhry, Nina Y. Wilson, Jeneva M. Garland
medRxiv 2024.01.12.24301126; doi: https://doi.org/10.1101/2024.01.12.24301126
Prevalence and Outcomes Associated with Idarucizumab Administration in Trauma Patients on Preinjury Dabigatran Therapy: Analyzing Clinical Utilization in 942 Patients from 74 Hospitals
Rebecca L. Moore, Ransom J. Wyse, Justin Jacobs, Samir M. Fakhry, Nina Y. Wilson, Jeneva M. Garland
medRxiv 2024.01.12.24301126; doi: https://doi.org/10.1101/2024.01.12.24301126
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)